These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16942039)

  • 1. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.
    Wentland MP; VanAlstine M; Kucejko R; Lou R; Cohen DJ; Parkhill AL; Bidlack JM
    J Med Chem; 2006 Sep; 49(18):5635-9. PubMed ID: 16942039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine.
    Wentland MP; Lu Q; Ganorkar R; Zhang SZ; Jo S; Cohen DJ; Bidlack JM
    Bioorg Med Chem Lett; 2009 Jan; 19(2):365-8. PubMed ID: 19091564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.
    Wentland MP; Ye Y; Cioffi CL; Lou R; Zhou Q; Xu G; Duan W; Dehnhardt CM; Sun X; Cohen DJ; Bidlack JM
    J Med Chem; 2003 Feb; 46(5):838-49. PubMed ID: 12593663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC.
    VanAlstine MA; Wentland MP; Cohen DJ; Bidlack JM
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6516-20. PubMed ID: 17935988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues.
    Wentland MP; Sun X; Ye Y; Lou R; Bidlack JM
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1911-4. PubMed ID: 12749896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines.
    Wentland MP; Lou R; Ye Y; Cohen DJ; Richardson GP; Bidlack JM
    Bioorg Med Chem Lett; 2001 Mar; 11(5):623-6. PubMed ID: 11266156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.
    Zhang A; Xiong W; Bidlack JM; Hilbert JE; Knapp BI; Wentland MP; Neumeyer JL
    J Med Chem; 2004 Jan; 47(1):165-74. PubMed ID: 14695830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of dynorphin a analogues modified in the address sequence.
    Schlechtingen G; DeHaven RN; Daubert JD; Cassel JA; Chung NN; Schiller PW; Taulane JP; Goodman M
    J Med Chem; 2003 May; 46(11):2104-9. PubMed ID: 12747782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.
    Wentland MP; Sun X; Cohen DJ; Bidlack JM
    Bioorg Med Chem; 2008 May; 16(10):5653-64. PubMed ID: 18417347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligands.
    Dolle RE; Machaut M; Martinez-Teipel B; Belanger S; Cassel JA; Stabley GJ; Graczyk TM; DeHaven RN
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3545-8. PubMed ID: 15177470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Carboxamidocyclazocine: a long-acting, novel benzomorphan.
    Bidlack JM; Cohen DJ; McLaughlin JP; Lou R; Ye Y; Wentland MP
    J Pharmacol Exp Ther; 2002 Jul; 302(1):374-80. PubMed ID: 12065740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.
    Thomas JB; Atkinson RN; Vinson NA; Catanzaro JL; Perretta CL; Fix SE; Mascarella SW; Rothman RB; Xu H; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 2003 Jul; 46(14):3127-37. PubMed ID: 12825951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the N-demethylation of 3-deoxymorphine and the affinity of the alkylation products to mu, delta, and kappa receptors.
    Csutoras C; Zhang A; Bidlack JM; Neumeyer JL
    Bioorg Med Chem; 2004 May; 12(10):2687-90. PubMed ID: 15110850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1.
    Takeuchi K; Holloway WG; McKinzie JH; Suter TM; Statnick MA; Surface PL; Emmerson PJ; Thomas EM; Siegel MG; Matt JE; Wolfe CN; Mitch CH
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5349-52. PubMed ID: 17720493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
    Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
    Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.